ٍٍٍ½خر

header-logo
GettyImages-609179959-hero
headshot

Mary M. Horowitz, MD, MS

Professor and Deputy Cancer Center Director; Robert A. Uihlein, Jr. Chair in Hematologic Research; Associate Director of Genomics; Scientific Director Emeritus, CIBMTR

view provider profile

Locations

  • Froedtert Hospital
  • Clinical Cancer Center - Froedtert Hospital

Specialties

  • Hematology
  • ٍٍٍ½خر Oncology

Languages

  • English

Education

  • MD - Doctor of Medicine
  • MS

Biography

Dr. Mary Horowitz currently holds the Robert A. Uihlein, Jr. Chair in Hematologic Research and is a tenured Professor of Medicine at the ٍٍٍ½خر (MCW), where she is also an active blood and marrow transplant physician. She is also Chief Scientific Director of the Center for International Blood and Marrow Transplant Research. She received MCW’s Distinguished Service Award in June 2006, MCW’s highest honor. In 2010, Dr. Horowitz received the American Society of Hematology Mentor Award. The award recognizes scientists who have dedicated their life to the process of guiding, supporting and promoting the training and career development of their junior colleagues. In 2014, Dr. Horowitz received the American Society of Blood and Marrow Transplant’s Lifetime Achievement Award in recognition of her contributions to the advancement of transplantation as a therapy for life-threatening diseases.

Research Interests

Dr. Horowitz is a member of the editorial boards of the journals Blood, Bone Marrow Transplantation, and Biology of Blood and Marrow Transplantation. She has served on the Board of Directors of the National Marrow Donor Program (NMDP) and as a member of the NMDP’s International Affairs Committee and, Research and Publications committees. Dr. Horowitz has served on the National Cancer Institute’s Cancer Clinical Investigation Review Committee, as well as on numerous advisory committees for public and private agencies, including the Data Safety and Monitoring Board of the National Heart Lung and Blood Institute’s Cord Blood Transplant Study, the Scientific Tumor Advisory Committee of the United Network for Organ Sharing, the Advisory Committee for the National Institute for Allergy and Infectious Disease Immune Tolerance Network and the 2005 Institute of Medicine Panel for Cord Blood Transplantation. She is the Principal Investigator of the Data and Coordinating Center of the U.S. Blood and Marrow Transplant Clinical Trials Network. She is also the Research and Project Director of the U.S. Stem Cell Therapeutic Outcomes Database, a component of the C.W. Bill Young Cell Transplantation Program, charged with collecting and assessing outcome data for all U.S. allogeneic transplants.

Dr. Horowitz has given more than 200 invited presentations on the subject of hematopoietic stem cell transplantation. Her research focuses on analysis of transplant outcomes with more than 250 papers in the biomedical literature.

Publications

  • (Hamilton BK, Lee CJ, Mattila D, El-Jawahri A, Cusatis RN, Brazauskas R, Sung AD, Phelan R, Horowitz MM, Lee SJ.) Blood Adv. 2026 Aug 25 PMID: 42641160 08/25/2026

  • (Bashey A, Logan B, Hill L, Symons H, Farhadfar N, Grunwald MR, Pidala J, Dehn JG, Brunstein C, Arai S, Leifer E, He N, Shaw BE, Juckett M, Devine S, Uberti J, Westervelt P, Srour SA, Pusic I, Vasu S, Hayes-Lattin B, Ciurea SO, Horowitz MM, Lee SJ, Hogan WJ.) Blood Adv. 2026 Aug 25;10(16):5543-5552 PMID: 42263667 PMCID: PMC13482518 SCOPUS ID: 2-s2.0-105047220932 06/10/2026

  • (Levis MJ, Hamadani M, Logan BR, Jones RJ, Singh AK, Litzow MR, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Ueda Oshima M, Uy GL, Waller EK, Vasu S, Solh MM, Mishra A, Muffly LS, Kim HJ, Stelljes M, Najima Y, Onozawa M, Thomson KJ, Chen C, Hasabou N, Rosales M, Hill JE, Gill SC, Nuthethi R, King D, Mendizabal AM, Devine SM, Horowitz MM, Chen YB.) Blood Adv. 2026 Jul 30 PMID: 42532509 07/31/2026

  • (Einarsdottir S, Fei T, Singh K, Martens M, Young JH, Bhavsar K, Kou J, Chen M, Lee LW, Baluch A, Dhodapkar MV, Nakamura R, Peyton K, Shahid Z, Armistead P, Westervelt P, McCarty J, McGuirk J, Hamadani M, Sharon E, Spahn A, Toor AA, Waldvogel S, Greenberger LM, Auletta JJ, Horowitz MM, Riches ML, Hosszu K, Hill JA, DeWolf S, Perales MA.) Blood Adv. 2026 Jun 09;10(11):3945-3959 PMID: 41941698 PMCID: PMC13235446 SCOPUS ID: 2-s2.0-105040358681 04/06/2026

  • (Artz AS, Logan B, Saber W, Geller N, Bellach A, Kou J, Wood WA, McCarty JM, Knight TG, Runaas L, Johnston L, Walston J, Nakamura R, Mishra A, Uberti J, Dahi PB, Saultz JN, McCurdy SR, Morris L, Imus P, Hogan WJ, Nadiminti K, Bhatt VR, Olin R, Maakaron J, Sobecks R, Wall S, Mattila D, Protz B, Devine SM, Horowitz MM, Sorror ML.) Blood Adv. 2026 Mar 10;10(5):1657-1669 PMID: 41269781 PMCID: PMC12955673 SCOPUS ID: 2-s2.0-105031366107 11/21/2025

  • (Wirbel J, Saber W, Martens MJ, Peled JU, Andermann TM, Fei T, Brooks EF, Doyle B, Pincus NB, Jenq RR, Bar M, Bolaños-Meade J, Bratrude B, Chhabra S, Choi SW, Clark W, Das S, Elmariah H, Gooptu M, Holtan SG, Jones RJ, Levine JE, Logan BR, Al Malki MM, Murthy HS, Rashidi A, Rezvani AR, Riches ML, Runaas L, Sandhu K, Spahn A, Sung AD, van den Brink MRM, Horowitz MM, Hamadani M, Kean LS, Perales MA, Bhatt AS.) bioRxiv. 2026 Feb 19 PMID: 41756883 PMCID: PMC12934721 02/27/2026

  • (Lee SJ, Logan B, Horowitz MM, Dehn JG, Pidala J, Grunwald MR, Westervelt P, Farhadfar N, Hogan WJ, Bashey A, Hayes-Lattin B, Hill L, Brunstein C, Arai S, Srour SA, Symons H, Uberti J, Vasu S, Pusic I, Juckett M, Leifer E, He N, Devine S, Shaw BE, Ciurea SO.) J Clin Oncol. 2025 Nov;43(31):3369-3380 PMID: 40966481 PMCID: PMC12700293 SCOPUS ID: 2-s2.0-105020636771 09/18/2025

  • (Levis MJ, Hamadani M, Logan BR, Jones RJ, Singh AK, Litzow MR, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Oshima MU, Uy GL, Waller EK, Vasu S, Solh M, Mishra A, Muffly LS, Kim HJ, Stelljes M, Najima Y, Onozawa M, Thomson K, Chen C, Hasabou N, Rosales M, Hill JE, Gill SC, Nuthethi R, King D, Mendizabal A, Devine SM, Horowitz MM, Chen YB.) Blood Adv. 2025 Oct 28;9(20):5123-5133 PMID: 40590852 PMCID: PMC12550156 07/01/2025

  • (Bhatt NS, Borogovac A, Efebera YA, DeSalvo A, Devine SM, Foley A, Greco-Stewart V, Hamilton BK, Heuer M, Molfenter T, Plastaras JP, Ragon BK, Wall SA, Broglie L, Juckett MB, Khera N, Horowitz MM, DeZern AE.) Blood Adv. 2025 Sep 09;9(17):4448-4457 PMID: 40554428 PMCID: PMC12410533 SCOPUS ID: 2-s2.0-105014911723 06/24/2025

  • (Abedin S, Martens MJ, Bolaños-Meade J, Al Malki MM, Lian Q, Runaas L, Elmariah H, Gooptu M, Larkin KT, Shaffer BC, Loren AW, Solh M, Alousi AM, Jamy OH, Perales MA, Rezvani A, Bhatt A, El Jurdi N, Yao JM, Applegate K, Kean LS, Efebera YA, Reshef R, Clark W, Leifer E, Saber W, Horowitz MM, Jones RJ, Holtan SG, Hamadani M.) Blood Adv. 2025 Jul 22;9(14):3495-3501 PMID: 40305657 PMCID: PMC12274666 SCOPUS ID: 2-s2.0-105011266148 04/30/2025

  • (Bröckelmann PJ, Cliff ERS, Iacoboni G, Simon F, Horowitz MM, Keating A, Mateos MV, Mohty M, Sidana S, Song Y, Wingard JR, Thanarajasingam G.) Lancet Haematol. 2025 Jun;12(6):e470-e481 PMID: 40447355 05/31/2025

  • (Wirbel J, Andermann TM, Brooks EF, Evans L, Groth A, Dvorak M, Chakraborty M, Palushaj B, Reynolds GZM, Porter IE, Al Malki M, Rezvani A, Gooptu M, Elmariah H, Runaas L, Fei T, Martens MJ, Bolaños-Meade J, Hamadani M, Holtan S, Jenq R, Peled JU, Horowitz MM, Poston KL, Saber W, Kean LS, Perales MA, Bhatt AS.) Cell Rep Methods. 2025 May 19;5(5):101030 PMID: 40300608 PMCID: PMC12146642 SCOPUS ID: 2-s2.0-105003827989 04/30/2025

Publications of from the

© 2026 ٍٍٍ½خر.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The ٍٍٍ½خر (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. MCW maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

MCW's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.